CN102083741B - pH敏感性金属纳米粒子及其制造方法 - Google Patents

pH敏感性金属纳米粒子及其制造方法 Download PDF

Info

Publication number
CN102083741B
CN102083741B CN200980125951.9A CN200980125951A CN102083741B CN 102083741 B CN102083741 B CN 102083741B CN 200980125951 A CN200980125951 A CN 200980125951A CN 102083741 B CN102083741 B CN 102083741B
Authority
CN
China
Prior art keywords
metal nanoparticle
compound
sensitive
metal
described compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200980125951.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN102083741A (zh
Inventor
金圣智
郑祥和
郑孝均
南周泽
元那渊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
POSTECH Academy Industry Foundation
Original Assignee
POSTECH Academy Industry Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by POSTECH Academy Industry Foundation filed Critical POSTECH Academy Industry Foundation
Publication of CN102083741A publication Critical patent/CN102083741A/zh
Application granted granted Critical
Publication of CN102083741B publication Critical patent/CN102083741B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0093—Purging against cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02—Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0285—Nanoscale sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/067—Radiation therapy using light using laser light
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Manufacturing & Machinery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN200980125951.9A 2008-07-03 2009-07-03 pH敏感性金属纳米粒子及其制造方法 Expired - Fee Related CN102083741B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020080064270A KR101014246B1 (ko) 2008-07-03 2008-07-03 페하 민감성 금속 나노 입자 및 이의 제조 방법.
KR10-2008-0064270 2008-07-03
PCT/KR2009/003640 WO2010002217A2 (ko) 2008-07-03 2009-07-03 페하 민감성 금속 나노 입자 및 이의 제조 방법

Publications (2)

Publication Number Publication Date
CN102083741A CN102083741A (zh) 2011-06-01
CN102083741B true CN102083741B (zh) 2015-11-25

Family

ID=41466491

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200980125951.9A Expired - Fee Related CN102083741B (zh) 2008-07-03 2009-07-03 pH敏感性金属纳米粒子及其制造方法

Country Status (6)

Country Link
US (2) US9616122B2 (https=)
EP (1) EP2308799B1 (https=)
JP (1) JP5577329B2 (https=)
KR (1) KR101014246B1 (https=)
CN (1) CN102083741B (https=)
WO (1) WO2010002217A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101196667B1 (ko) * 2010-04-15 2012-11-02 포항공과대학교 산학협력단 피에이치 민감성 금속 나노 입자를 이용한 항암제 전달 시스템
KR101276693B1 (ko) * 2010-10-29 2013-06-19 포항공과대학교 산학협력단 양쪽성 이온을 가진 나노입자 표면 개질용 표면 분자체의 합성과 그 응용
KR101368179B1 (ko) * 2010-11-12 2014-03-03 포항공과대학교 산학협력단 강한 전하를 가지는 나노입자 표면 분자체와 이를 이용한 생접합 및 층상 자기조립 방법
WO2012174287A1 (en) * 2011-06-15 2012-12-20 The Board Of Regents Of The University Of Texas System Luminescent nanoparticle compositions
US20130189367A1 (en) * 2011-07-29 2013-07-25 University Of Washington Through Its Center For Commercialization Nanovectors for targeted gene silencing and cytotoxic effect in cancer cells
CN102989016A (zh) * 2012-11-05 2013-03-27 浙江大学 一种具有pH敏感性的纳米微粒材料及其制备方法
KR20140092430A (ko) * 2012-12-26 2014-07-24 삼성전자주식회사 나노입자 조립체, 이의 제조방법 및 이를 포함하는 활성물질 전달 복합체
US9784730B2 (en) 2013-03-21 2017-10-10 University Of Washington Through Its Center For Commercialization Nanoparticle for targeting brain tumors and delivery of O6-benzylguanine
US9874554B1 (en) 2014-07-16 2018-01-23 Verily Life Sciences Llc Aptamer-based in vivo diagnostic system
CN104667301B (zh) * 2015-02-12 2017-08-22 东北师范大学 一种单分散核壳结构AuNCs‑A@CaP纳米粒子的制备方法及其应用
JP2019512486A (ja) * 2016-03-08 2019-05-16 チルドレンズ ナショナル メディカル センターＣｈｉｌｄｒｅｎ’Ｓ Ｎａｔｉｏｎａｌ Ｍｅｄｉｃａｌ Ｃｅｎｔｅｒ 官能化されたプルシアンブルーナノ粒子、組合せプルシアンブルーナノ粒子ベースのナノ免疫療法およびその適用
CN107941778A (zh) * 2017-10-11 2018-04-20 南方医科大学南方医院 一种用于检测体液pH的传感器及其制备和应用方法
CN111514308B (zh) * 2020-03-10 2023-02-17 西南民族大学 pH诱导电荷翻转型抗菌金纳米棒及其制备方法和应用
CN113899732B (zh) * 2021-09-30 2023-09-22 航天科工(长沙)新材料研究院有限公司 pH值敏感型配体修饰纳米金及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020103517A1 (en) * 2000-02-08 2002-08-01 West Jennifer L. Optically-active nanoparticles for use in therapeutic and diagnostic methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340527C (en) * 1988-05-31 1999-05-04 Lidia Vallarino Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities
DE60115667T2 (de) 2000-09-05 2006-08-24 Centelion Säureempfindliche verbindungen, deren herstellung und verwendungen
GB0321937D0 (en) 2003-09-19 2003-10-22 Univ Liverpool Nanoparticle conjugates and method of production thereof
US7601331B2 (en) * 2004-11-10 2009-10-13 National University Of Singapore NIR-sensitive nanoparticle
KR100645597B1 (ko) 2005-03-24 2006-11-14 이지로보틱스 주식회사 로봇 리모컨 서비스 방법 및 장치
KR100713745B1 (ko) * 2006-02-27 2007-05-07 연세대학교 산학협력단 상전이 리간드로 코팅된 수용성 자성 또는 금속 산화물나노입자 및 이의 제조방법
KR20080008668A (ko) 2006-07-20 2008-01-24 재단법인서울대학교산학협력재단 자성체 나노입자를 이용하여 단백질을 선택적으로 결합,분리 또는 정제하는 방법
KR100802080B1 (ko) 2007-03-28 2008-02-11 성균관대학교산학협력단 ｐＨ 민감성 블록 공중합체 및 이를 이용한 고분자 마이셀

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020103517A1 (en) * 2000-02-08 2002-08-01 West Jennifer L. Optically-active nanoparticles for use in therapeutic and diagnostic methods

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
A General Strategy Toward pH-Controlled Aggregation–Dispersion of Gold Nanoparticles and Single-Walled Carbon Nanotubes;Xiaogang Han et al.;《small》;20080213;第4卷(第3期);第326-329页 *
A Protein Nanocarrier from Charge-Conversion Polymer in Response to Endosomal pH;Yan Lee et al.;《J. AM. CHEM. SOC.》;20070405;第129卷;第5362-5363页 *
Enhanced Intracellular Delivery of Quantum Dot and Adenovirus Nanoparticles Triggered by Acidic pH via Surface Charge Reversal;Hyejung Mok et al.;《Bioconjugate Chemistry》;20080326;第19卷(第4期);第797-801页 *
Gold Nanoparticles Protected with pH and Temperature-Sensitive Diblock Copolymers;Markus Nuopponen et al.;《Langmuir》;20070413;第23卷;第5352-5357页 *
Modulation of in Vivo Tumor Radiation Response via Gold Nanoshell-Mediated Vascular-Focused Hyperthermia: Characterizing an Integrated Antihypoxic and Localized Vascular Disrupting Targeting Strategy;Parmeswaran Diagaradjane et al.;《NANO LETTERS》;20080416;第8卷(第5期);第1492-1500页 *
Peiwen Zheng et al..Formation of GoldPolymer Core-Shell Particles and Gold Particle Clusters on a Template of Thermoresponsive and pH-Responsive Coordination Triblock Copolymer.《Langmuir》.2006,第22卷第9393-9396页. *
Reversible aggregation of gold nanoparticles induced by pH dependent conformational transitions of a self-assembled polypeptide;Jeung-Yeop Shim et al.;《Journal of Colloid and Interface Science》;20070814;第316卷;第977-983页 *
Synthesis and Grafting of Thioctic Acid-PEG-Folate Conjugates onto Au Nanoparticles for Selective Targeting of Folate Receptor-Positive Tumor Cells;Vivechana Dixit et al.;《Bioconjugate Chem.》;20060503;第17卷;第603-609页 *

Also Published As

Publication number Publication date
KR20100004220A (ko) 2010-01-13
EP2308799B1 (en) 2017-11-08
KR101014246B1 (ko) 2011-02-16
JP2011526883A (ja) 2011-10-20
US20170226474A1 (en) 2017-08-10
WO2010002217A2 (ko) 2010-01-07
US9616122B2 (en) 2017-04-11
JP5577329B2 (ja) 2014-08-20
WO2010002217A3 (ko) 2010-06-24
EP2308799A4 (en) 2014-12-17
CN102083741A (zh) 2011-06-01
US20110269170A1 (en) 2011-11-03
EP2308799A2 (en) 2011-04-13

Similar Documents

Publication Publication Date Title
CN102083741B (zh) pH敏感性金属纳米粒子及其制造方法
Singh et al. Carbon quantum dots: Synthesis, characterization and biomedical applications
Liang et al. Recent progress in the development of upconversion nanomaterials in bioimaging and disease treatment
Chang et al. Self-assembled CeVO 4/Ag nanohybrid as photoconversion agents with enhanced solar-driven photocatalysis and NIR-responsive photothermal/photodynamic synergistic therapy performance
Hou et al. UV-emitting upconversion-based TiO2 photosensitizing nanoplatform: near-infrared light mediated in vivo photodynamic therapy via mitochondria-involved apoptosis pathway
Cui et al. Amphiphilic chitosan modified upconversion nanoparticles for in vivo photodynamic therapy induced by near-infrared light
Song et al. Design of Near Infrared Light‐Powered Copper Phyllosilicate Nanomotors for Cuproptosis‐Based Synergistic Cancer Therapy
CN105969331B (zh) 一种适用于靶向药物载体的纳米材料的制备方法
Rita Kakkar ZnO quantum dots for biomedical applications
CN107184978B (zh) 一种硫化铜@介孔二氧化硅纳米复合材料及其制备方法和用途
CN101775280B (zh) 一种水溶性核壳磁光双功能纳米粒子及其制备方法
Molaei Turmeric-derived gadolinium-doped carbon quantum dots for multifunctional fluorescence imaging and MRI contrast agent
CN113817469B (zh) 一种生物窗口内激发/发射的超亮单色上转换纳米探针及其制备方法和应用
CN104027806A (zh) 一种修饰CuS纳米粒子的介孔二氧化硅包覆四氧化三锰的纳米材料及其制备方法和应用
Kumar et al. In vitro and bioimaging studies of mesoporous silica nanocomposites encapsulated iron-oxide and loaded doxorubicin drug (DOX/IO@ Silica) as magnetically guided drug delivery system
CN108175859B (zh) 一种多模磁光热诊疗一体化纳米探针及其制备方法和应用
CN116041247B (zh) 一种光热试剂、光热试剂纳米颗粒及其制备方法
CN114209825A (zh) 亚铜离子响应的no释放和光热协同治疗剂及其应用
KR101731140B1 (ko) 멜라닌 나노입자를 포함하는 광음향 영상화제
CN107158381A (zh) 一种具有光热增强效应的金纳米星@硫化铜光热探针的制备方法及其应用
CN106913871B (zh) 一种用作肿瘤光热消融诊疗剂的铂铜纳米晶及制备方法
KR101001906B1 (ko) 페하 민감성 화합물 및 그 제조 방법
Mikalauskaite et al. Designing red-fluorescent superparamagnetic nanoparticles by conjugation with gold clusters
TWI459965B (zh) 生物可相容的糖花狀金奈米粒子、其製備方法及其生物醫學應用
Ilie-Mihai et al. Carbon Nanodots in Nanobiomedicines and Electrochemical Sensing Devices

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151125

Termination date: 20180703

CF01 Termination of patent right due to non-payment of annual fee